Literature DB >> 10698006

Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB/c mice.

T Kita1, K Shimada, Y Mastunari, G C Wagner, K Kubo, T Nakashima.   

Abstract

The expression of cyclooxygenase-2 (COX-2) and striatal dopamine (DA) depletion in BALB/cAnNcrj (BALB/c) mice following a neurotoxic dose of methamphetamine (METH) was investigated. METH-treatment (4 mg/kg x 4, 2 h intervals, s.c.) induced a significant hyperthermia and a persistent depletion of striatal DA levels 72 h after the treatment. COX-2, a marker of the cytotoxic effect of inflammation and oxidative stress and thiobarbituric acid (TBA) were significantly induced in the striatum 72 h after the METH-treatment, but not in the hippocampus. These results suggest that COX-2 may participate in METH-induced neurotoxicity in striatum.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10698006     DOI： 10.1016/s0028-3908(99)00175-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


  14 in total

1.  Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

Authors:  Winnie Jeng; Peter G Wells
Journal:  ACS Chem Neurosci       Date:  2010-02-23       Impact factor: 4.418

2.  Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine.

Authors:  M D Gutierrez-Lopez; N Llopis; S Feng; D A Barrett; E O'Shea; M I Colado
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 3.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

4.  Neuroprotective Effects of Anti-high Mobility Group Box-1 Monoclonal Antibody Against Methamphetamine-Induced Dopaminergic Neurotoxicity.

Authors:  Kaori Masai; Keita Kuroda; Nami Isooka; Ryo Kikuoka; Shinki Murakami; Sunao Kamimai; Dengli Wang; Keyue Liu; Ikuko Miyazaki; Masahiro Nishibori; Masato Asanuma
Journal:  Neurotox Res       Date:  2021-08-21       Impact factor: 3.911

5.  Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine.

Authors:  Kristen A Horner; Yamiece E Gilbert; Susan D Cline
Journal:  Front Syst Neurosci       Date:  2011-05-09

Review 6.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

7.  Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier.

Authors:  Nicole A Northrop; Bryan K Yamamoto
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-26       Impact factor: 4.147

8.  Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.

Authors:  Takeshi Tsuji; Masato Asanuma; Ikuko Miyazaki; Ko Miyoshi; Norio Ogawa
Journal:  Neurochem Res       Date:  2008-10-23       Impact factor: 3.996

9.  SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.

Authors:  Matthew J Robson; Ryan C Turner; Zachary J Naser; Christopher R McCurdy; Jason D Huber; Rae R Matsumoto
Journal:  Exp Neurol       Date:  2013-04-28       Impact factor: 5.330

10.  Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.

Authors:  Nicole A Northrop; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2013-05-02       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.